Imiquimod maleate is primarily used in the treatment of certain skin conditions. It is commonly prescribed for external genital and perianal warts caused by the human papillomavirus (HPV). The compound works by stimulating the immune system to target and eliminate the affected cells, thereby reducing the size and number of warts. Additionally, it is used to treat superficial basal cell carcinoma, a type of skin cancer, particularly in cases where surgical removal is not feasible. Imiquimod maleate is also effective in managing actinic keratosis, a precancerous skin condition caused by prolonged sun exposure. Its immunomodulatory properties make it a valuable option for these dermatological applications, offering a non-invasive treatment alternative.